Trial Profile

Phase 1, multicentre, open-label, dose finding trial of forodesine in patients with relapsed B-cell chronic lymphocytic leukemia.

Status: Discontinued

Phase of Trial: Phase I

Latest Information Update: 03 Apr 2010

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Forodesine (Primary)
Indications Chronic lymphocytic leukaemia
Focus Therapeutic Use
Sponsors Mundipharma International

Most Recent Events

02 Apr 2010 Planned end date changed from 1 Feb 2010 to 1 May 2009 as reported by ClinicalTrials.gov.
02 Apr 2010 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
05 Aug 2008 Actual start date has changed from Mar 2008 to Jul 2008 as reported by ClinicalTrials.gov.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com